DDX39B

Spliceosome RNA helicase DDX39B · Q13838 · DDX39B on Sugi Atlas →

0 patent compounds predicted against DDX39B, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to DDX39B by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer PHASE2COMPLETED
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants nanRECRUITING
DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. nanCOMPLETED
Better Delineation of DDX3X Related Phenotype and Epigenetic Signature. nanUNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study nanRECRUITING
International PPB/DICER1 Registry nanRECRUITING
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer nanCOMPLETED
Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders nanCOMPLETED
Molecular Disease Profile of Hematological Malignancies nanUNKNOWN
Genetic Investigation of Cancer Predisposition nanNOT_YET_RECRUITING
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Shwachman Diamond Syndrome Registry and Study nanRECRUITING
B3 for NMD: Bench to Bedside and Back nanENROLLING_BY_INVITATION
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF) nanCOMPLETED
Prognostic Molecular Markers in Patients With Myelodysplastic Syndrome nanCOMPLETED
Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study) nanRECRUITING
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping nanUNKNOWN
Brain Involvement in Myotonic Dystrophy Type I: From Functional Neuroimaging to the Impact on Quality of Life nanCOMPLETED
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome nanCOMPLETED
Immunophenotyping and Xist Gene in AML nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a DDX39B binder may also engage these)

ProteinNameSimilarity
P60024 1.000 P60024 →
Q63413 1.000 Q63413 →
Q5RE47 1.000 Q5RE47 →
Q5ZHZ0 1.000 Q5ZHZ0 →
Q5TM17 1.000 Q5TM17 →
Q3T147 1.000 Q3T147 →
Q29024 1.000 Q29024 →
Q9Z1N5 1.000 Q9Z1N5 →
Q5WR10 1.000 Q5WR10 →
Q27268 1.000 Q27268 →
Q8VDW0 1.000 Q8VDW0 →
O13792 1.000 O13792 →
Q5U216 1.000 Q5U216 →
Q56XG6 1.000 Q56XG6 →
Q0JM17 1.000 Q0JM17 →
O00148 1.000 O00148 →
Q2H4D0 1.000 Q2H4D0 →
A5DDN0 1.000 A5DDN0 →
Q5JK84 1.000 Q5JK84 →
Q2U6P7 1.000 Q2U6P7 →
A7TLA0 1.000 A7TLA0 →
A4RBS3 1.000 A4RBS3 →
P0CQ97 1.000 P0CQ97 →
A6R603 1.000 A6R603 →
Q6FL17 1.000 Q6FL17 →
Q6CM95 1.000 Q6CM95 →
A1DL85 1.000 A1DL85 →
Q0TXZ2 1.000 Q0TXZ2 →
A1CMQ7 1.000 A1CMQ7 →
Q5ASK8 1.000 Q5ASK8 →